SCHEMBL19082044

SCHEMBL19082044

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5cc6sc7c8ccccc8ccc7c6c6oc7ccccc7c56)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A1 P04798 4/20 0.33
CYP1B1 Q16678 4/20 0.33
CYP1A2 P05177 2/20 0.33
ALOX5 P09917 2/20 0.33
PSD A5PKW4 1/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31
ARSA P15289 1/20 0.31
CDC25A P30304 1/20 0.31
CDC25C P30307 1/20 0.31
ESR2 Q92731 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082007 0.91 CYP1A1 (0.37) TDP1L3MBTL1CYP1A1CYP1B1CYP1A2
SCHEMBL19082047 0.87 TDP1 (0.36) TDP1L3MBTL1CYP1A1CYP1B1CYP1A2
SCHEMBL19081651 0.82 TDP1 (0.40) TDP1L3MBTL1CYP1A1CYP1B1CYP1A2
SCHEMBL17932157 0.82 ALOX5 (0.40) TDP1L3MBTL1ALOX5PSDMAOA
SCHEMBL19080333 0.82 CYP1A1 (0.40) L3MBTL1CYP1A1CYP1B1CYP1A2MAOA
SCHEMBL19082367 0.81 CYP1A1 (0.37) L3MBTL1CYP1A1CYP1B1CYP1A2ALOX5
SCHEMBL19076784 0.81 ALOX5 (0.40) TDP1L3MBTL1CYP1A1CYP1B1CYP1A2
SCHEMBL19081969 0.81 CYP1A1 (0.36) TDP1L3MBTL1CYP1A1CYP1B1CYP1A2
SCHEMBL19082028 0.80 CYP1A1 (0.36) TDP1L3MBTL1CYP1A1CYP1B1CYP1A2
SCHEMBL19081806 0.79 TDP1 (0.36) TDP1L3MBTL1CYP1A2ALOX5PSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.